Stem Cell Transplantation
MSC transplantation and hydroxyapatite ceramics treat severe osteochondral damage
Published in Blood Weekly, October 27th, 2005
"We describe a 21-year-old man with a large osteochondral defect of the knee after septic arthritis, successfully treated by transplant of mesenchymal stein cells (MSC) front bone marrow and a new type of interconnected porous hydroxyapatite ceramic (IP-CHA).
"We confirmed successful cartilage-like tissue regeneration by a second arthroscopy," wrote investigators in Japan.
"Biopsy of the repaired tissue revealed cartilage-like regeneration and bone formation. We were able to regenerate new bone and cartilage-like tissue...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-10-27)
More Articles from Blood Weekly
- Hemophilia
U.S. FDA approves room temperature storage of Helixate FS - Stem Cell Research
Hematopoietic stem cells age-related changes favor myelopoiesis - Stem Cell Transplantation
Donor infusions result in residual/relapsed lymphoid malignancy remission - Acute Myeloid Leukemia
EMEA grants orphan drug designation to Troxatyl for acute myeloid leukemia - Adverse Drug Reaction
Drugs raise mitochondrial toxicity risk in HIV/hepatitis C-coinfected patients - Angiology
Synthetic 23-amino acid peptide drug accelerates blood vessel growth, study shows - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
